PIM Kinases in Multiple Myeloma

Wu, J; Chu, E; Kang, YB

Kang, YB (corresponding author), Duke Univ Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Med, Durham, NC 27710 USA.

CANCERS, 2021; 13 (17):

Abstract

Simple Summary Multiple myeloma is the second most common hematologic malignancy in the United States. Eventually, all myeloma patients will relapse a......

Full Text Link